Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
Substance use disorders (SUDs) are common and frequently co-occur with mood and anxiety disorders. This paper provides a detailed analysis of patterns, prevalence and correlates of mood and anxiety disorders among those with a (i) pure SUD; (ii) SUD plus a mood or anxiety disorder (SUDs + 1); and (iii) SUD plus a mood and anxiety disorder (SUDs + 2).



Data came from the 2007 National Survey of Mental Health and Wellbeing; a nationally representative household survey of 8841 Australians aged 16-85 years.



The 12-month prevalence of SUDs was 5.1%. Of those with a 12-month SUD, 65% met the criteria for pure SUDs, 19% for SUDs + 1 and 16% for SUDs + 2. Major depression was the most common mood disorder in both comorbid groups. One-third of SUDs + 1 experienced social phobia, while over half of SUDs + 2 experienced generalised anxiety disorder. Compared with pure SUDs, SUDs + 1 experienced two times more and SUDs + 2 experienced over four times more days out of role in the preceding 30 days. Both comorbid groups were more likely to experience severe levels of impairment. SUDs + 2 were over 18 times more likely to experience suicidal thoughts in the same year. SUDs + 1 were over three times and SUDs + 2 were over 10 times more likely to have had one or more consultations with a health professional in the previous year.



These findings highlight the complexities inherent with responding to and treating multiple comorbidities among substance users and emphasise the need for coordinated, cohesive responses from drug and alcohol treatment services.[Prior K, Mills K, Ross J, Teesson M. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug Alcohol Rev 2017;36:317-324].
National Health and Medical Research Council Centre of Research Excellence in Mental Health and Substance Use, Sydney, Australia.|National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Katrina
K
Prior
National Health and Medical Research Council Centre of Research Excellence in Mental Health and Substance Use, Sydney, Australia.|National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Katherine
K
Mills
National Health and Medical Research Council Centre of Research Excellence in Mental Health and Substance Use, Sydney, Australia.|National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Joanne
J
Ross
National Health and Medical Research Council Centre of Research Excellence in Mental Health and Substance Use, Sydney, Australia.|National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Maree
M
Teesson
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001008:Anxiety Disorders / Q000175:diagnosis* / Q000453:epidemiology* / Q000523:psychology; D001315:Australia / Q000453:epidemiology; D015897:Comorbidity; D005260:Female; D006306:Health Surveys / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D019964:Mood Disorders / Q000175:diagnosis* / Q000453:epidemiology* / Q000523:psychology; D011159:Population Surveillance / Q000379:methods; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000453:epidemiology* / Q000523:psychology; D055815:Young Adult
anxiety disorder; comorbidity; mood disorder; prevalence; substance use disorder